Fully-funded PhD projects

Apply for our fully-funded PhD projects in subjects including chemistry, biology, computer science, and physics.

PhD opportunities for science graduates

Projects for the 2024/2025 PhD studentships are below. You will also find a link to further information about our application process and our mailing list, should you wish to be notified about future PhD opportunities. You can also view the recording of the 2023 Application Workshop, where we heard from our Academic Lead for Recruitment, Head of Research Degree Programmes and Researcher Development Manager. We also had advice and guidance from the University of London Careers Service, and an insight from some of our current PhD students at the ICR.

Stipends

The ICR's current student stipend is £26,050 per year. Studentships awarded by the Cancer Research UK Convergence Science Centre, which is a partnership of the ICR and Imperial College London, instead includes a stipend paid at the Cancer Research UK rate of £23,000 per year.

Find out about our application process

Mailing list

Available opportunities

You can view details of the 2024/2025 projects below. 

Any future applications will be added here so please do check back regularly.

Funding for our PhD projects comes from a variety of different sources, including some funded programmes, such as the MRC Doctoral Training Partnership and the CRUK Science Centre at the ICR and Imperial.  

Apply now for convergence Science non-clinical PhD Black Leaders in Cancer projects

Please note, the advertised funder may change prior to registration.

 

 

See all our PhD projects:

Closed: Triple Negative Breast cancer control of the immune tumour microenvironment in metastasis

Primary supervisor: Professor Victoria Sanz-Moreno Primary site: Chelsea Funded by UKRI

Closed: Examining the mechanism of chromatin telomere replication

Primary supervisor: Dr Max Douglas Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Closed: Modifiable lifestyle factors and breast cancer survival and recurrence

Primary site: Sutton Funded by Breast Cancer Now £25,000 per year

Closed: Investigating the cytoprotective role of the ectonucleotidase CD38 in immune responses to cancer

Primary supervisor: Dr Esther Arwert Primary site: Sutton Funded by ICR £25,000 per year

Closed: Role of the non-coding genome in the evolution of myeloma

Primary site: Sutton Funded by ICR £25,000 per year

Closed: Development of automatic plan-of-the-day selection tools for radiation therapy of pelvic cancer

Primary supervisor: Dr Shaista Hafeez Primary site: Sutton Funded by Biomedical Research Centre (BRC) £25,000 per year

Closed: Late-effects of hypofractionated radiotherapy for breast cancer

Primary supervisor: Professor Amy Berrington Primary site: Sutton Funded by ICR £25,000 per year

Closed: Advancing clinical elastography for early, non-invasive imaging assessment of normal tissue toxicity and tumour response

Primary supervisor: Dr Jessica Winfield Primary site: Sutton Funded by NIHR BRC at RMH/ICR £25,000 per year

Closed: Enhancing immune responses to radiation with spatiotemporal dose modulation and drug combinations

Primary supervisor: Dr Magnus Dillon Primary site: Sutton Funded by CRUK RadNet

Closed: HPV- and genome instability-driven innate immune responses in head and neck cancer

Primary supervisor: Dr Ben O'Leary Primary site: Chelsea Funded by CRUK RadNet

Closed: Investigating how myeloid populations may modify radiotherapy/immunotherapy responses in muscle-invasive bladder cancer

Primary supervisor: Dr Anna Wilkins Primary site: Sutton Funded by CRUK RadNet

Closed: Molecular investigation on MuvB oncogenic complexes

Primary supervisor: Dr Claudio Alfieri Primary site: Chelsea Funded by ICR

Closed: Hyper-activation of oncogenic signalling to treat colorectal tumours

Primary supervisor: Professor Trevor Graham Primary site: Sutton Funded by MRC iCASE Award (Merck)

Closed: Development of small molecules targeting the TRF1 subunit of the telomeric Shelterin complex

Primary supervisor: Professor Sebastian Guettler Primary site: Sutton Funded by MRC iCASE Award (Merck)

Closed: Enabling novel E3 ligases for targeted protein degradation therapeutics

Primary site: Sutton Funded by Medical Research Council - Doctoral Training Partnership (MRC DTP)

Closed: Immunopeptidome landscape of multiple myeloma

Primary supervisor: Professor Richard Houlston Primary site: Sutton Funded by ICR